Array Technologies Inc
(NASDAQ: ARRY)

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. The drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target pathways. The Company�s drug candidates include AMG 151, MEK162, ARRY-380, ARRY-520, ARRY-543 and ARRY-614.

8.370 -

-0.600 (-6.69%)
Jarak 8.275 - 9.050   (9.37%)
Buka 8.970
Tutup Terdahulu 8.970
Harga Beli 8.370
Beli Purata 501
Jual Beli 8.380
Purata Jual 1,119
Purata 3,120,561
Nilai 17,135,715
Catatan -
Harga tertunda. Dikemas kini pada 19 May 2026 03:29.
Data dikuasakan oleh
Lihat Semua Acara

Mengenai Array Technologies

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. The drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target pathways. The Company�s drug candidates include AMG 151, MEK162, ARRY-380, ARRY-520, ARRY-543 and ARRY-614.

Loading Chart...

Please login to view stock data and analysis